These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 19262285)

  • 1. Therapy of large multinodular goitre using repeated doses of radioiodine.
    Baczyk M; Pisarek M; Czepczyński R; Ziemnicka K; Gryczyńska M; Pietz L; Sowiński J
    Nucl Med Commun; 2009 Mar; 30(3):226-31. PubMed ID: 19262285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
    Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
    Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT).
    Czarnywojtek A; Czepczynski R; Ruchala M; Wasko R; Zgorzalewicz-Stachowiak M; Szczepanek E; Zamyslowska H; Bartkowiak Z; Florek E; Sowinski J
    Neuro Endocrinol Lett; 2009; 30(2):209-14. PubMed ID: 19675515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioiodine therapy for thyroid volume reduction of large goitres.
    Bachmann J; Kobe C; Bor S; Rahlff I; Dietlein M; Schicha H; Schmidt M
    Nucl Med Commun; 2009 Jun; 30(6):466-71. PubMed ID: 19381116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multinodular goiter management in Western Saudi Arabia.
    Qari FA
    Saudi Med J; 2005 Mar; 26(3):438-41. PubMed ID: 15806215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
    Bakker SC; Zanin DE; Zweers EJ
    Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of administering 0.2 mg of recombinant human TSH for two consecutive days as an adjuvant to therapy with low radioiodine doses in elderly out-patients with large nontoxic multinodular goiter.
    Giusti M; Cappi C; Santaniello B; Ceresola E; Augeri C; Lagasio C; Minuto F
    Minerva Endocrinol; 2006 Sep; 31(3):191-209. PubMed ID: 17213787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism.
    Romão R; Rubio IG; Tomimori EK; Camargo RY; Knobel M; Medeiros-Neto G
    Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of the optimal minimum radioiodine dose in patients with Graves' disease: a clinical outcome study.
    Howarth D; Epstein M; Lan L; Tan P; Booker J
    Eur J Nucl Med; 2001 Oct; 28(10):1489-95. PubMed ID: 11685491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of long-term results of two schedules of treatment for toxic multinodular goitre with radioiodine therapy (I 131).
    Khanna CM; Magdum M; Ravishankar L; Dham DN; Chugh P
    J Assoc Physicians India; 1996 Feb; 44(2):102-5. PubMed ID: 10999060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The treatment of multinodular large non-toxic goiter using repeated doses of radioiodine (preliminary report)].
    Pisarek M; Baczyk M; Gryczyńska M; Sowiński J
    Endokrynol Pol; 2007; 58(1):18-26. PubMed ID: 17354201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human TSH increases the efficacy of a fixed activity of radioiodine for treatment of multinodular goitre.
    Cubas ER; Paz-Filho GJ; Olandoski M; Goedert CA; Woellner LC; Carvalho GA; Graf H
    Int J Clin Pract; 2009 Apr; 63(4):583-90. PubMed ID: 18803554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetry and risk estimates of radioiodine therapy for large, multinodular goiters.
    Huysmans DA; Buijs WC; van de Ven MT; van den Broek WJ; Kloppenborg PW; Hermus AR; Corstens FH
    J Nucl Med; 1996 Dec; 37(12):2072-9. PubMed ID: 8970537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results of two schedules of treatment for toxic multinodular goitre with radioiodine therapy.
    Khanna CM; Magdam M; Ravishankar L; Dham DN; Chugh P
    J Assoc Physicians India; 1995 Oct; 43(10):685-8. PubMed ID: 8773004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External dose rates in radioiodine treatment of benign goitre: estimation versus direct measurement.
    Jørgensen HB; Høilund-Carlsen PF; Nielsen VE
    Scand J Clin Lab Invest; 2006; 66(6):509-16. PubMed ID: 17000558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Volume reduction of the thyroid after radioiodine therapy in patients with autonomous goiter and Basedow's goiter].
    Dederichs B; Otte R; Klink JE; Schicha H
    Nuklearmedizin; 1996 Oct; 35(5):164-9. PubMed ID: 9005412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of longterm outcome of radioiodine therapy of sporadic non-toxic goitre.
    Le Moli R; Wesche MF; Tiel-Van Buul MM; Wiersinga WM
    Clin Endocrinol (Oxf); 1999 Jun; 50(6):783-9. PubMed ID: 10468951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioiodine therapy in hyperthyroidism: inverse correlation of pretherapeutic iodine uptake level and post-therapeutic outcome.
    Walter MA; Christ-Crain M; Eckard B; Schindler C; Nitzsche EU; Müller-Brand J; Müller B
    Eur J Clin Invest; 2004 May; 34(5):365-70. PubMed ID: 15147334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioiodine therapy of benign thyroid disorders: what are the effective thyroidal half-life and uptake of 131I?
    Kobe C; Eschner W; Wild M; Rahlff I; Sudbrock F; Schmidt M; Dietlein M; Schicha H
    Nucl Med Commun; 2010 Mar; 31(3):201-5. PubMed ID: 19907353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.